SCHEMBL403900

SCHEMBL403900

CN(CC(=O)OC(C)(C)C)Cc1ccc(C#N)cc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
ABCB1 P08183 4/20 0.41
POLB P06746 1/20 0.39
P2RX7 Q99572 1/20 0.38
PDK1 Q15118 1/20 0.38
PDK2 Q15119 1/20 0.38
PDK3 Q15120 1/20 0.38
PDK4 Q16654 1/20 0.38
EPHX2 P34913 1/20 0.38
ALDH1A1 P00352 1/20 0.37
NR3C1 P04150 1/20 0.37
PGR P06401 1/20 0.37
NR3C2 P08235 1/20 0.37
PYCR1 P32322 2/20 0.36
CYP19A1 P11511 1/20 0.35
NCEH1 Q6PIU2 1/20 0.35
FNTA P49354 1/20 0.34
FNTB P49356 1/20 0.34
MRGPRX4 Q96LA9 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL405794 0.92 HTT (0.47) HTTNPSR1ABCB1POLBPDK1
SCHEMBL408930 0.87 ABCB1 (0.42) HTTNPSR1ABCB1POLBFNTA
SCHEMBL406404 0.86 ABCB1 (0.41) HTTNPSR1ABCB1NR3C1PGR
SCHEMBL408771 0.86 ABCB1 (0.41) HTTNPSR1ABCB1POLBPYCR1
SCHEMBL410797 0.85 ABCB1 (0.41) HTTNPSR1ABCB1POLBALDH1A1
SCHEMBL2775844 0.84 ABCB1 (0.42) HTTNPSR1ABCB1POLBFNTA
SCHEMBL410467 0.84 ABCB1 (0.40) HTTNPSR1ABCB1POLBFNTA
SCHEMBL405751 0.84 ABCB1 (0.40) HTTNPSR1ABCB1EPHX2ALDH1A1
SCHEMBL5912934 0.83 HTT (0.45) HTTNPSR1ABCB1P2RX7PDK1
SCHEMBL16109970 0.82 PDK1 (0.42) HTTNPSR1ABCB1P2RX7PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2414341-B1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2017-09-13 EP disclosed
EP-2414342-B1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2017-05-31 EP disclosed
US-8815919-B2 Oxadiazole derivatives MERCK SERONO SA (CH) 2014-08-26 US disclosed
US-8802704-B2 Oxadiazole derivatives MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-20120035226-A1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2012-02-09 US disclosed
EP-2414341-A2 OXADIAZOLE DERIVATIVES Merck Serono SA (CH) 2012-02-08 EP disclosed
EP-2414342-A1 OXADIAZOLE DERIVATIVES Merck Serono S.A. (CH) 2012-02-08 EP disclosed
US-20120022109-A1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2012-01-26 US disclosed
WO-2010115751-A2 OXADIAZOLE DERIVATIVES MERCK SERONO S.A. (CH) 2010-10-14 WO disclosed
WO-2010112461-A1 OXADIAZOLE DERIVATIVES MERCK SERONO S.A. (CH) 2010-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022109-A1 OXADIAZOLE DERIVATIVES OXA1L, HLA-DRB1, SSB HTT 4073/4885NPSR1 3160/4885ABCB1 1198/4885
US-20120035226-A1 OXADIAZOLE DERIVATIVES OXA1L, HLA-DRB1, SSB HTT 4073/4885NPSR1 3160/4885ABCB1 1198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.